Evommune, Inc. (EVMN NYSE) stock market data APIs
$16.9965
-0.35(-2.1%)
as of February 9, 2026
Try our APIs with
free plan!
Evommune, Inc. Financial Data Overview
Price chart is built with
Anychart
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.
Prev. Close
16.9965
Open
16.6467
High
17.0023
Low
16.0114
52 wk Range
13.885-24.03
Market Cap
0
EPS
-8.07
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Evommune, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evommune, Inc. data using free add-ons & libraries
Get Evommune, Inc. Fundamental Data
Evommune, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-11
- EPS/Forecast: -11.35
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evommune, Inc. News
New
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026
Microscope and test tubes beside a laptop showing a rising chart signal biotech progress and improving stock momentum. Key Points Three biotech names with promising clinical trial data and a history...
Carvana initiated, Zscaler downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
Evommune, BillionToOne set IPO price
[IPO Concept with Stock Market Graphs] Evommune (EVMN [https://seekingalpha.com/symbol/EVMN]), a biotechnology startup, has set the price for its initial public offering at $16 per share for approxim...
NYSE Content Advisory: Pre-Market Update + Evommune & Aeromexico Begin Trading
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
